首页 > 最新文献

Diagnosis最新文献

英文 中文
How case reports can be used to improve diagnosis. 如何利用病例报告改进诊断。
IF 2.2 Q1 Medicine Pub Date : 2024-01-19 eCollection Date: 2024-05-01 DOI: 10.1515/dx-2023-0181
Kosuke Ishizuka, Shun Yamashita, Yuichiro Mine, Yukichika Yamamoto, Hiroki Kojima, Hidehiro Someko, Taiju Miyagami
{"title":"How case reports can be used to improve diagnosis.","authors":"Kosuke Ishizuka, Shun Yamashita, Yuichiro Mine, Yukichika Yamamoto, Hiroki Kojima, Hidehiro Someko, Taiju Miyagami","doi":"10.1515/dx-2023-0181","DOIUrl":"10.1515/dx-2023-0181","url":null,"abstract":"","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139485208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Future of Diagnosis: Navigating Uncertainty. 诊断的未来:驾驭不确定性。
IF 3.5 Q1 Medicine Pub Date : 2024-01-19 eCollection Date: 2024-05-01 DOI: 10.1515/dx-2023-0178
{"title":"The Future of Diagnosis: Navigating Uncertainty.","authors":"","doi":"10.1515/dx-2023-0178","DOIUrl":"10.1515/dx-2023-0178","url":null,"abstract":"","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139485219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical assessment of Ortho VITROS SARS-CoV-2 antigen chemiluminescence immunoassay. Ortho VITROS SARS-CoV-2 抗原化学发光免疫测定的临床评估。
IF 3.5 Q1 Medicine Pub Date : 2024-01-19 eCollection Date: 2024-05-01 DOI: 10.1515/dx-2023-0182
Laura Pighi, Gian Luca Salvagno, Nicole Bertoldi, Brandon M Henry, Giuseppe Lippi
{"title":"Clinical assessment of Ortho VITROS SARS-CoV-2 antigen chemiluminescence immunoassay.","authors":"Laura Pighi, Gian Luca Salvagno, Nicole Bertoldi, Brandon M Henry, Giuseppe Lippi","doi":"10.1515/dx-2023-0182","DOIUrl":"10.1515/dx-2023-0182","url":null,"abstract":"","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139485205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The consequences of delayed diagnosis and treatment in persons with multiple sclerosis given autologous hematopoietic stem cell transplantation. 对接受自体造血干细胞移植的多发性硬化症患者进行延迟诊断和治疗的后果。
IF 3.5 Q1 Medicine Pub Date : 2024-01-18 eCollection Date: 2024-05-01 DOI: 10.1515/dx-2023-0157
María de Lourdes Pastelín-Martínez, Moisés Manuel Gallardo-Pérez, Andrés Gómez-de-León, Juan Carlos Olivares-Gazca, Edgar Jared Hernández-Flores, Daniela Sánchez-Bonilla, Merittzel Montes-Robles, Max Robles-Nasta, Guillermo Ocaña-Ramm, Silvia Soto-Olvera, David Gómez-Almaguer, Guillermo J Ruiz-Delgado, Guillermo J Ruiz-Argüelles

Objectives: We have analyzed the association of delayed both diagnosis and treatment of persons with MS with the long-term results of patients given autologous hematopoietic stem cell transplantation (aHSCT).

Methods: Patients with MS referred to the HSCT-Mexico program were included in the study; in 103, detailed pre- and post-transplant evolution could be recorded. Two groups of patients were analyzed according to the time of evolution between the onset of symptoms and the definite diagnosis of MS: more than 8 months (delayed diagnosis, DD), or less than 8 months (non-delayed diagnosis, NDD). The progression of MS was assessed by changes in the expanded disability status scale (EDSS).

Results: The time elapsed between the onset of symptoms and the correct diagnosis was lower for the NDD group (1.55 vs. 35.87 months, p<0.05). Both groups of patients showed a similar EDSS score at diagnosis (1.5 vs. 1.5); however, the EDSS at the time of the transplant was higher in the DD group (4.5 vs. 3.0, p=0.3) and the response of the EDSS score to the transplant was significantly better for the NDD group, the last EDSS scores being 2.5 vs. 4.25 (p=0.03). Both groups of patients responded to aHSCT by diminishing the EDSS, but the response was significantly better in the NDD group.

Conclusions: These data indicate that both the pre-transplant progression of the disease and the response to aHSCT were significantly worse in the DD group. An early diagnosis and an early aHSCT intervention are critical for a good prognosis, in terms of lowering and stabilizing the motor disability in MS patients given autografts.

目的我们分析了多发性硬化症患者诊断和治疗延迟与接受造血干细胞移植患者长期疗效的关系:研究对象包括转诊至墨西哥造血干细胞移植项目的多发性硬化症患者;其中 103 例患者的移植前后演变情况均有详细记录。根据多发性硬化症从症状出现到确诊之间的演变时间,对两组患者进行了分析:超过8个月(延迟诊断,DD)或少于8个月(非延迟诊断,NDD)。多发性硬化症的进展情况通过扩大残疾状况量表(EDSS)的变化进行评估:结果:NDD 组患者从出现症状到得到正确诊断的时间较短(1.55 个月 vs. 35.87 个月,p):这些数据表明,DD组患者移植前的病情发展和对aHSCT的反应都明显较差。早期诊断和早期 aHSCT 干预对良好预后至关重要,可降低和稳定接受自体移植的多发性硬化症患者的运动障碍。
{"title":"The consequences of delayed diagnosis and treatment in persons with multiple sclerosis given autologous hematopoietic stem cell transplantation.","authors":"María de Lourdes Pastelín-Martínez, Moisés Manuel Gallardo-Pérez, Andrés Gómez-de-León, Juan Carlos Olivares-Gazca, Edgar Jared Hernández-Flores, Daniela Sánchez-Bonilla, Merittzel Montes-Robles, Max Robles-Nasta, Guillermo Ocaña-Ramm, Silvia Soto-Olvera, David Gómez-Almaguer, Guillermo J Ruiz-Delgado, Guillermo J Ruiz-Argüelles","doi":"10.1515/dx-2023-0157","DOIUrl":"10.1515/dx-2023-0157","url":null,"abstract":"<p><strong>Objectives: </strong>We have analyzed the association of delayed both diagnosis and treatment of persons with MS with the long-term results of patients given autologous hematopoietic stem cell transplantation (aHSCT).</p><p><strong>Methods: </strong>Patients with MS referred to the HSCT-Mexico program were included in the study; in 103, detailed pre- and post-transplant evolution could be recorded. Two groups of patients were analyzed according to the time of evolution between the onset of symptoms and the definite diagnosis of MS: more than 8 months (delayed diagnosis, DD), or less than 8 months (non-delayed diagnosis, NDD). The progression of MS was assessed by changes in the expanded disability status scale (EDSS).</p><p><strong>Results: </strong>The time elapsed between the onset of symptoms and the correct diagnosis was lower for the NDD group (1.55 vs. 35.87 months, p<0.05). Both groups of patients showed a similar EDSS score at diagnosis (1.5 vs. 1.5); however, the EDSS at the time of the transplant was higher in the DD group (4.5 vs. 3.0, p=0.3) and the response of the EDSS score to the transplant was significantly better for the NDD group, the last EDSS scores being 2.5 vs. 4.25 (p=0.03). Both groups of patients responded to aHSCT by diminishing the EDSS, but the response was significantly better in the NDD group.</p><p><strong>Conclusions: </strong>These data indicate that both the pre-transplant progression of the disease and the response to aHSCT were significantly worse in the DD group. An early diagnosis and an early aHSCT intervention are critical for a good prognosis, in terms of lowering and stabilizing the motor disability in MS patients given autografts.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139478116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of saliva-based qPCR diagnostics for the accurate, rapid, and inexpensive detection of strep throat. 利用基于唾液的 qPCR 诊断技术,准确、快速、低成本地检测链球菌咽喉炎。
IF 3.5 Q1 Medicine Pub Date : 2024-01-05 eCollection Date: 2024-05-01 DOI: 10.1515/dx-2023-0134
Madeline H Peachey, Kristopher E Kubow, Kristina B Blyer, Julia A Halterman

Objectives: Outpatient health care facilities are essential for quickly diagnosing common infectious diseases such as bacterial and viral pharyngitis. The only form of pharyngitis requiring antibiotics is strep throat (ST); however, antibiotic prescription rates are much higher than ST prevalence, suggesting antibiotics are being inappropriately prescribed. Current rapid ST diagnostics may be contributing to this problem due to the low sensitivity and variable specificity of these tests. It is best practice to verify a negative ST diagnosis with a group A Streptococcus (GAS) culture, but many clinics do not perform this test due to the additional cost and 24-72 h required to obtain results. This indicates there is great need for more accurate rapid diagnostic tools in outpatient facilities. We hypothesized that next generation qPCR technology could be adapted to detect GAS DNA from saliva samples (instead of the traditional throat swab) by creating a simple, fast, and inexpensive protocol.

Methods: Saliva specimens collected from patients at James Madison University Health Center were used to test the effectiveness of our Chelex 100-based rapid DNA extraction method, followed by a fast protocol developed for the Open qPCR machine to accurately detect ST.

Results: Our final saliva processing and qPCR protocol required no specialized training to perform and was able to detect ST with 100 % sensitivity and 100 % specificity (n=102) in 22-26 min, costing only $1.12 per sample.

Conclusions: Saliva can be rapidly analyzed via qPCR for the accurate and inexpensive detection of ST.

目的:门诊医疗机构对于快速诊断细菌性和病毒性咽炎等常见传染病至关重要。唯一需要使用抗生素的咽炎是链球菌性咽喉炎(ST);然而,抗生素处方率远远高于 ST 发病率,这表明抗生素处方不当。目前的快速 ST 诊断方法可能是造成这一问题的原因之一,因为这些检测方法的灵敏度低且特异性不一。最佳做法是用 A 组链球菌(GAS)培养来验证 ST 阴性诊断结果,但由于费用昂贵且需要 24-72 小时才能获得结果,许多诊所并不进行这种检测。这表明门诊机构亟需更准确的快速诊断工具。我们推测,下一代 qPCR 技术可用于检测唾液样本(而非传统的咽拭子)中的 GAS DNA,方法简单、快速且成本低廉:方法:从詹姆斯-麦迪逊大学健康中心的患者唾液样本中收集的样本被用来测试我们基于 Chelex 100 的快速 DNA 提取方法的有效性,然后使用为 Open qPCR 仪器开发的快速方案来准确检测 ST:结果:我们最终的唾液处理和 qPCR 方案无需专业培训即可执行,并能在 22-26 分钟内检测出 ST,灵敏度和特异性均为 100%(n=102),每个样本的成本仅为 1.12 美元:结论:通过 qPCR 可以快速分析唾液,准确、低成本地检测 ST。
{"title":"Use of saliva-based qPCR diagnostics for the accurate, rapid, and inexpensive detection of strep throat.","authors":"Madeline H Peachey, Kristopher E Kubow, Kristina B Blyer, Julia A Halterman","doi":"10.1515/dx-2023-0134","DOIUrl":"10.1515/dx-2023-0134","url":null,"abstract":"<p><strong>Objectives: </strong>Outpatient health care facilities are essential for quickly diagnosing common infectious diseases such as bacterial and viral pharyngitis. The only form of pharyngitis requiring antibiotics is strep throat (ST); however, antibiotic prescription rates are much higher than ST prevalence, suggesting antibiotics are being inappropriately prescribed. Current rapid ST diagnostics may be contributing to this problem due to the low sensitivity and variable specificity of these tests. It is best practice to verify a negative ST diagnosis with a group A <i>Streptococcus</i> (GAS) culture, but many clinics do not perform this test due to the additional cost and 24-72 h required to obtain results. This indicates there is great need for more accurate rapid diagnostic tools in outpatient facilities. We hypothesized that next generation qPCR technology could be adapted to detect GAS DNA from saliva samples (instead of the traditional throat swab) by creating a simple, fast, and inexpensive protocol.</p><p><strong>Methods: </strong>Saliva specimens collected from patients at James Madison University Health Center were used to test the effectiveness of our Chelex 100-based rapid DNA extraction method, followed by a fast protocol developed for the Open qPCR machine to accurately detect ST.</p><p><strong>Results: </strong>Our final saliva processing and qPCR protocol required no specialized training to perform and was able to detect ST with 100 % sensitivity and 100 % specificity (n=102) in 22-26 min, costing only $1.12 per sample.</p><p><strong>Conclusions: </strong>Saliva can be rapidly analyzed via qPCR for the accurate and inexpensive detection of ST.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139097547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Journal Reputation Factor. 期刊声誉因子。
IF 3.5 Q1 Medicine Pub Date : 2024-01-01 eCollection Date: 2024-02-01 DOI: 10.1515/dx-2023-0165
Eleftherios P Diamandis
{"title":"Journal Reputation Factor.","authors":"Eleftherios P Diamandis","doi":"10.1515/dx-2023-0165","DOIUrl":"10.1515/dx-2023-0165","url":null,"abstract":"","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139073634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-analytical errors in coagulation testing: a case series. 凝血检测中的分析前误差:病例系列。
IF 3.5 Q1 Medicine Pub Date : 2024-01-01 eCollection Date: 2024-02-01 DOI: 10.1515/dx-2023-0110
Mala Mahto, Visesh Kumar, Ayan Banerjee, Sushil Kumar, Anurag Kumar

Objectives: Prevention of pre-analytical issues in coagulation testing is of paramount importance for good laboratory performance. In addition to common issues like hemolysed, icteric, or lipemic samples, some specific pre-analytical errors of coagulation testing include clotted specimens, improper blood-to-anticoagulant ratio, contamination with other anticoagulants, etc. Prothrombin time (PT) and activated partial thromboplastin time (aPTT) are very commonly affected tests due to pre-analytical variables. The impact these parameters possess on surgical decision-making and various life-saving interventions are substantial therefore we cannot afford laxity and casual mistakes in carrying out these critical investigations at all.

Case presentation: In this case series, a total of 4 cases of unexpectedly deranged coagulation profiles have been described which were reported incorrectly due to the overall casual approach towards these critical investigations. We have also mentioned how the treating clinician and lab physician retrospectively accessed relevant information in the nick of time to bring back reassurance.

Conclusions: Like every other critical investigation, analytical errors can occur in coagulation parameters due to various avoidable pre-analytical variables. The release of spurious results for coagulation parameters sets alarm bells ringing causing much agony to the treating doctor and patient. Only a disciplined and careful approach taken by hospital and lab staff towards each sample regardless of its criticality can negate these stressful errors to a large extent.

目的:预防凝血检测中的分析前问题对实验室的良好表现至关重要。除了溶血、黄疸或脂血样本等常见问题外,凝血检测中一些特殊的分析前错误还包括样本凝结、血液与抗凝剂比例不当、受其他抗凝剂污染等。凝血酶原时间(PT)和活化部分凝血活酶时间(aPTT)是非常常见的因分析前变量而受影响的检测项目。这些参数对手术决策和各种挽救生命的干预措施具有重大影响,因此我们在进行这些关键检查时绝不能松懈和随意出错:在本病例系列中,共描述了 4 例意外凝血功能失常的病例,由于对这些关键检查的整体随意性,这些病例被错误报告。我们还提到了主治临床医生和实验室医生是如何在关键时刻回顾性地获取相关信息,从而使患者恢复信心的:与其他所有关键检查一样,凝血参数也会因各种可避免的分析前变量而出现分析错误。虚假的凝血参数结果一经公布,就会给医生和患者敲响警钟,造成极大的痛苦。只有医院和实验室工作人员对每个样本(无论其关键性如何)都采取严谨细致的态度,才能在很大程度上避免这些令人紧张的错误。
{"title":"Pre-analytical errors in coagulation testing: a case series.","authors":"Mala Mahto, Visesh Kumar, Ayan Banerjee, Sushil Kumar, Anurag Kumar","doi":"10.1515/dx-2023-0110","DOIUrl":"10.1515/dx-2023-0110","url":null,"abstract":"<p><strong>Objectives: </strong>Prevention of pre-analytical issues in coagulation testing is of paramount importance for good laboratory performance. In addition to common issues like hemolysed, icteric, or lipemic samples, some specific pre-analytical errors of coagulation testing include clotted specimens, improper blood-to-anticoagulant ratio, contamination with other anticoagulants, etc. Prothrombin time (PT) and activated partial thromboplastin time (aPTT) are very commonly affected tests due to pre-analytical variables. The impact these parameters possess on surgical decision-making and various life-saving interventions are substantial therefore we cannot afford laxity and casual mistakes in carrying out these critical investigations at all.</p><p><strong>Case presentation: </strong>In this case series, a total of 4 cases of unexpectedly deranged coagulation profiles have been described which were reported incorrectly due to the overall casual approach towards these critical investigations. We have also mentioned how the treating clinician and lab physician retrospectively accessed relevant information in the nick of time to bring back reassurance.</p><p><strong>Conclusions: </strong>Like every other critical investigation, analytical errors can occur in coagulation parameters due to various avoidable pre-analytical variables. The release of spurious results for coagulation parameters sets alarm bells ringing causing much agony to the treating doctor and patient. Only a disciplined and careful approach taken by hospital and lab staff towards each sample regardless of its criticality can negate these stressful errors to a large extent.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139058216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interleukin-6, tumor necrosis factor-α, and high-sensitivity C-reactive protein for optimal immunometabolic profiling of the lifestyle-related cardiorenal risk. 白细胞介素-6、肿瘤坏死因子-α 和高敏 C 反应蛋白可优化与生活方式有关的心肾风险的免疫代谢分析。
IF 3.5 Q1 Medicine Pub Date : 2024-01-01 eCollection Date: 2024-02-01 DOI: 10.1515/dx-2023-0159
Georgina Noel Marchiori, María Daniela Defagó, María Lucía Baraquet, Sebastián Del Rosso, Nilda Raquel Perovic, Elio Andrés Soria

Objectives: The present study aimed to identify optimal inflammatory biomarkers involved in cardiorenal risk in response to major lifestyle factors.

Methods: One hundred and twenty-nine adults aged 35-77 years participated voluntarily from 2017 to 2019 (Córdoba, Argentina) in a cross-sectional study to collect sociodemographic, clinical, and lifestyle data. Blood biomarkers (different cytokines, monocyte chemoattractant protein-1 [MCP-1], and high-sensitivity C-reactive protein [hs-CRP]) were measured using standard methods and then evaluated by principal component analysis and structural equation modeling (SEM) according to Mediterranean diet adherence, physical activity level, and waist circumference, while cardiorenal risk involved blood diastolic pressure, HDL-cholesterol, triacylglycerols, creatinine, and glycosylated hemoglobin.

Results: A principal component included TNF-α (tumor necrosis factor-alpha), IL-8 (interleukin-8), IL-6 (interleukin-6), hs-CRP, and MCP-1, with absolute rotated factor loadings >0.10. SEM showed that IL-6 (β=0.38, 95 % IC=0.08-0.68), hs-CRP (β=0.33, 95 % IC=0.17-0.48), and TNF-α (β=0.22, 95 % IC=0.11-0.32) were the mediators that better explained an inflammatory profile positively related to waist circumference (β=0.77, 95 % IC=0.61-0.94). Moreover, this profile was associated with an increased cardiorenal risk (β=0.78, 95 % IC=0.61-0.94), which was well-defined by the variable used.

Conclusions: Immune mediators are key elements in profiling the cardiorenal risk associated with lifestyle factors, for which the combination of hs-CRP, IL-6, and TNF-α has emerged as a robust indicator. This work reaffirms the need for biomarker optimization for early diagnosis and risk assessment.

目的:本研究旨在确定与主要生活方式因素有关的心血管风险的最佳炎症生物标志物:本研究旨在确定与主要生活方式因素有关的心力衰竭风险的最佳炎症生物标志物:129名35-77岁的成年人自愿参加了2017年至2019年(阿根廷科尔多瓦)的一项横断面研究,以收集社会人口学、临床和生活方式数据。采用标准方法测量了血液生物标志物(不同的细胞因子、单核细胞趋化蛋白-1 [MCP-1]和高敏C反应蛋白[hs-CRP]),然后根据地中海饮食坚持率、体力活动水平和腰围,通过主成分分析和结构方程模型(SEM)进行了评估,而心血管风险则涉及血液舒张压、高密度脂蛋白胆固醇、三酰甘油、肌酐和糖化血红蛋白:主成分包括 TNF-α(肿瘤坏死因子-α)、IL-8(白细胞介素-8)、IL-6(白细胞介素-6)、hs-CRP 和 MCP-1,旋转因子载荷绝对值大于 0.10。SEM 显示,IL-6(β=0.38,95 % IC=0.08-0.68)、hs-CRP(β=0.33,95 % IC=0.17-0.48)和 TNF-α(β=0.22,95 % IC=0.11-0.32)是能更好地解释与腰围(β=0.77,95 % IC=0.61-0.94)正相关的炎症特征的中介因子。此外,该特征还与心肾风险增加有关(β=0.78,95 % IC=0.61-0.94),这一点在所用变量中得到了很好的界定:结论:免疫介质是分析与生活方式因素相关的心肾风险的关键因素,hs-CRP、IL-6 和 TNF-α 的组合已成为一个可靠的指标。这项工作再次证明了优化生物标志物以进行早期诊断和风险评估的必要性。
{"title":"Interleukin-6, tumor necrosis factor-α, and high-sensitivity C-reactive protein for optimal immunometabolic profiling of the lifestyle-related cardiorenal risk.","authors":"Georgina Noel Marchiori, María Daniela Defagó, María Lucía Baraquet, Sebastián Del Rosso, Nilda Raquel Perovic, Elio Andrés Soria","doi":"10.1515/dx-2023-0159","DOIUrl":"10.1515/dx-2023-0159","url":null,"abstract":"<p><strong>Objectives: </strong>The present study aimed to identify optimal inflammatory biomarkers involved in cardiorenal risk in response to major lifestyle factors.</p><p><strong>Methods: </strong>One hundred and twenty-nine adults aged 35-77 years participated voluntarily from 2017 to 2019 (Córdoba, Argentina) in a cross-sectional study to collect sociodemographic, clinical, and lifestyle data. Blood biomarkers (different cytokines, monocyte chemoattractant protein-1 [MCP-1], and high-sensitivity C-reactive protein [hs-CRP]) were measured using standard methods and then evaluated by principal component analysis and structural equation modeling (SEM) according to Mediterranean diet adherence, physical activity level, and waist circumference, while cardiorenal risk involved blood diastolic pressure, HDL-cholesterol, triacylglycerols, creatinine, and glycosylated hemoglobin.</p><p><strong>Results: </strong>A principal component included TNF-α (tumor necrosis factor-alpha), IL-8 (interleukin-8), IL-6 (interleukin-6), hs-CRP, and MCP-1, with absolute rotated factor loadings >0.10. SEM showed that IL-6 (β=0.38, 95 % IC=0.08-0.68), hs-CRP (β=0.33, 95 % IC=0.17-0.48), and TNF-α (β=0.22, 95 % IC=0.11-0.32) were the mediators that better explained an inflammatory profile positively related to waist circumference (β=0.77, 95 % IC=0.61-0.94). Moreover, this profile was associated with an increased cardiorenal risk (β=0.78, 95 % IC=0.61-0.94), which was well-defined by the variable used.</p><p><strong>Conclusions: </strong>Immune mediators are key elements in profiling the cardiorenal risk associated with lifestyle factors, for which the combination of hs-CRP, IL-6, and TNF-α has emerged as a robust indicator. This work reaffirms the need for biomarker optimization for early diagnosis and risk assessment.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139058215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of a diagnosis flow draft based on appearance impression for detection of vulvar disease. 应用基于外观印象的诊断流程图检测外阴疾病。
IF 3.5 Q1 Medicine Pub Date : 2023-12-26 eCollection Date: 2024-05-01 DOI: 10.1515/dx-2023-0146
Qi Zhou, Fang Chen, Yan Wang, Wenjie Qu, Yingxin Gong, Yuankui Cao, Hongwei Zhang, Qing Wang, Limei Chen, Qing Cong, Lin Lin, Jiayin Mo, Tianyi Bi, Jingxin Ding, Long Sui, Yanyun Li

Objectives: The aims of this retrospective study were to evaluate the clinical applicability of the latest International Society for the Study of Vulvovaginal Disease (ISSVD) and International Federation for Cervical Pathology and Colposcopy (IFCPC) terminology for vulvar diseases, and to explore a new evaluation flow to optimize decision-making on diagnosis.

Methods: A total of 1,068 patients with 5,340 qualified vulvar images were evaluated by observers using 2011 ISSVD and 2011 IFCPC terminology systems. The sensitivity, specificity, positive predictive value, negative predictive value, Youden Index and Overall Diagnostic Value (ODV) were calculated for each finding in the two systems. Then the disease diagnosis order and a diagnosis flow draft (DFD) were obtained.

Results: A total of 15 kinds of vulvar diseases were diagnosed. The proportion of patients accompanied with cervical or vaginal intraepithelial neoplasia was highest (83.3 %) in vulvar Paget's disease group (p<0.001). Total area of lesions was larger in vulvar Paget's disease, lichen simplex chronicus and lichen sclerosus group (p<0.001). Among the top five findings of ODV, some findings inferred several (≥6) kinds of diseases, while some findings only exist in a certain disease. When the DFD was used, the agreement between the initial impression and histopathology diagnosis was 68.8 %, higher than those when ISSVD an IFCPC terminology systems used (p=0.028), and it didn't change with the experience of the observer (p=0.178).

Conclusions: Based on the findings in ISSVD and IFCPC terminology systems, we explored a DFD for observers with different experience on the detection of vulvar disease.

研究目的这项回顾性研究旨在评估国际外阴阴道疾病研究学会(ISSVD)和国际宫颈病理学和阴道镜联合会(ICPC)最新术语对外阴疾病的临床适用性,并探索一种新的评估流程,以优化诊断决策。方法:观察者使用 2011 ISSVD 和 2011 IFCPC 术语系统对 1,068 名患者的 5,340 张合格外阴图像进行评估。计算两个系统中每项发现的敏感性、特异性、阳性预测值、阴性预测值、Youden 指数和总体诊断价值(ODV)。然后得出疾病诊断顺序和诊断流程图(DFD):结果:共诊断出 15 种外阴疾病。结果:共诊断出 15 种外阴疾病,其中外阴帕吉特氏病组中伴有宫颈或阴道上皮内瘤变的患者比例最高(83.3%)(p 结论:外阴帕吉特氏病组中伴有宫颈或阴道上皮内瘤变的患者比例最高(83.3%):根据 ISSVD 和 IFCPC 术语系统的研究结果,我们为具有不同外阴疾病检测经验的观察者探索了一种 DFD。
{"title":"Application of a diagnosis flow draft based on appearance impression for detection of vulvar disease.","authors":"Qi Zhou, Fang Chen, Yan Wang, Wenjie Qu, Yingxin Gong, Yuankui Cao, Hongwei Zhang, Qing Wang, Limei Chen, Qing Cong, Lin Lin, Jiayin Mo, Tianyi Bi, Jingxin Ding, Long Sui, Yanyun Li","doi":"10.1515/dx-2023-0146","DOIUrl":"10.1515/dx-2023-0146","url":null,"abstract":"<p><strong>Objectives: </strong>The aims of this retrospective study were to evaluate the clinical applicability of the latest International Society for the Study of Vulvovaginal Disease (ISSVD) and International Federation for Cervical Pathology and Colposcopy (IFCPC) terminology for vulvar diseases, and to explore a new evaluation flow to optimize decision-making on diagnosis.</p><p><strong>Methods: </strong>A total of 1,068 patients with 5,340 qualified vulvar images were evaluated by observers using 2011 ISSVD and 2011 IFCPC terminology systems. The sensitivity, specificity, positive predictive value, negative predictive value, Youden Index and Overall Diagnostic Value (ODV) were calculated for each finding in the two systems. Then the disease diagnosis order and a diagnosis flow draft (DFD) were obtained.</p><p><strong>Results: </strong>A total of 15 kinds of vulvar diseases were diagnosed. The proportion of patients accompanied with cervical or vaginal intraepithelial neoplasia was highest (83.3 %) in vulvar Paget's disease group (p<0.001). Total area of lesions was larger in vulvar Paget's disease, lichen simplex chronicus and lichen sclerosus group (p<0.001). Among the top five findings of ODV, some findings inferred several (≥6) kinds of diseases, while some findings only exist in a certain disease. When the DFD was used, the agreement between the initial impression and histopathology diagnosis was 68.8 %, higher than those when ISSVD an IFCPC terminology systems used (p=0.028), and it didn't change with the experience of the observer (p=0.178).</p><p><strong>Conclusions: </strong>Based on the findings in ISSVD and IFCPC terminology systems, we explored a DFD for observers with different experience on the detection of vulvar disease.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139032127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What's going well: a qualitative analysis of positive patient and family feedback in the context of the diagnostic process. 进展顺利:诊断过程中患者和家属积极反馈的定性分析。
IF 3.5 Q1 Medicine Pub Date : 2023-12-20 eCollection Date: 2024-02-01 DOI: 10.1515/dx-2023-0075
Stephen K Liu, Fabienne Bourgeois, Joe Dong, Kendall Harcourt, Elizabeth Lowe, Liz Salmi, Eric J Thomas, Natalie Riblet, Sigall K Bell

Objectives: Accurate and timely diagnosis relies on close collaboration between patients/families and clinicians. Just as patients have unique insights into diagnostic breakdowns, positive patient feedback may also generate broader perspectives on what constitutes a "good" diagnostic process (DxP).

Methods: We evaluated patient/family feedback on "what's going well" as part of an online pre-visit survey designed to engage patients/families in the DxP. Patients/families living with chronic conditions with visits in three urban pediatric subspecialty clinics (site 1) and one rural adult primary care clinic (site 2) were invited to complete the survey between December 2020 and March 2022. We adapted the Healthcare Complaints Analysis Tool (HCAT) to conduct a qualitative analysis on a subset of patient/family responses with ≥20 words.

Results: In total, 7,075 surveys were completed before 18,129 visits (39 %) at site 1, and 460 surveys were completed prior to 706 (65 %) visits at site 2. Of all participants, 1,578 volunteered positive feedback, ranging from 1-79 words. Qualitative analysis of 272 comments with ≥20 words described: Relationships (60 %), Clinical Care (36 %), and Environment (4 %). Compared to primary care, subspecialty comments showed the same overall rankings. Within Relationships, patients/families most commonly noted: thorough and competent attention (46 %), clear communication and listening (41 %) and emotional support and human connection (39 %). Within Clinical Care, patients highlighted: timeliness (31 %), effective clinical management (30 %), and coordination of care (25 %).

Conclusions: Patients/families valued relationships with clinicians above all else in the DxP, emphasizing the importance of supporting clinicians to nurture effective relationships and relationship-centered care in the DxP.

目标:准确及时的诊断有赖于患者/家属和临床医生之间的密切合作。正如患者对诊断失误有独到见解一样,患者的积极反馈也能为 "良好 "诊断过程(DxP)的构成提供更广泛的视角:我们评估了患者/家属对 "进展顺利 "的反馈意见,这是旨在让患者/家属参与诊断过程的在线就诊前调查的一部分。我们邀请在三家城市儿科亚专科诊所(地点 1)和一家农村成人初级保健诊所(地点 2)就诊的慢性病患者/家属在 2020 年 12 月至 2022 年 3 月期间完成调查。我们改编了医疗投诉分析工具(HCAT),对字数≥20 字的患者/家属回复子集进行了定性分析:在医疗点 1,共有 7,075 份调查问卷在 18,129 次就诊前完成(占 39%);在医疗点 2,共有 460 份调查问卷在 706 次就诊前完成(占 65%)。在所有参与者中,1,578 人自愿提供了正面反馈,字数在 1-79 字之间。对 272 条≥20 个字的意见进行了定性分析:关系(60%)、临床护理(36%)和环境(4%)。与初级医疗相比,亚专科评论的总体排名相同。在 "人际关系 "方面,患者/家属最常提到的是:全面和称职的关注(46%)、清晰的沟通和倾听(41%)以及情感支持和人际交往(39%)。在临床护理方面,患者强调:及时性(31%)、有效的临床管理(30%)和护理协调(25%):结论:在 DxP 中,患者/家属最看重的是与临床医生的关系,强调了在 DxP 中支持临床医生培养有效关系和以关系为中心的护理的重要性。
{"title":"What's going well: a qualitative analysis of positive patient and family feedback in the context of the diagnostic process.","authors":"Stephen K Liu, Fabienne Bourgeois, Joe Dong, Kendall Harcourt, Elizabeth Lowe, Liz Salmi, Eric J Thomas, Natalie Riblet, Sigall K Bell","doi":"10.1515/dx-2023-0075","DOIUrl":"10.1515/dx-2023-0075","url":null,"abstract":"<p><strong>Objectives: </strong>Accurate and timely diagnosis relies on close collaboration between patients/families and clinicians. Just as patients have unique insights into diagnostic breakdowns, positive patient feedback may also generate broader perspectives on what constitutes a \"good\" diagnostic process (DxP).</p><p><strong>Methods: </strong>We evaluated patient/family feedback on \"what's going well\" as part of an online pre-visit survey designed to engage patients/families in the DxP. Patients/families living with chronic conditions with visits in three urban pediatric subspecialty clinics (site 1) and one rural adult primary care clinic (site 2) were invited to complete the survey between December 2020 and March 2022. We adapted the Healthcare Complaints Analysis Tool (HCAT) to conduct a qualitative analysis on a subset of patient/family responses with ≥20 words.</p><p><strong>Results: </strong>In total, 7,075 surveys were completed before 18,129 visits (39 %) at site 1, and 460 surveys were completed prior to 706 (65 %) visits at site 2. Of all participants, 1,578 volunteered positive feedback, ranging from 1-79 words. Qualitative analysis of 272 comments with ≥20 words described: Relationships (60 %), Clinical Care (36 %), and Environment (4 %). Compared to primary care, subspecialty comments showed the same overall rankings. Within Relationships, patients/families most commonly noted: thorough and competent attention (46 %), clear communication and listening (41 %) and emotional support and human connection (39 %). Within Clinical Care, patients highlighted: timeliness (31 %), effective clinical management (30 %), and coordination of care (25 %).</p><p><strong>Conclusions: </strong>Patients/families valued relationships with clinicians above all else in the DxP, emphasizing the importance of supporting clinicians to nurture effective relationships and relationship-centered care in the DxP.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10875277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138800992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Diagnosis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1